Compound Radar

Azenta, Inc. (AZTA) Stock Analysis

Price $30.82
Market cap $1.44B
Next earnings Nov 20, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

63
63/100 Good Quality
  • Financial Health 70
  • Profitability 40
  • Business Quality 60
  • Balance Sheet 65
  • Cash Flow 80

Why this rating?

Health 63/100 — Good Quality

Strongest Cash Flow 80/100
Softest Profitability 40/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Azenta, Inc. (AZTA) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Azenta, Inc. 63/100 (Good Quality) due to solid business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Elevated

Financial highlights

Valuation

  • Forward P/E 56.09
  • PEG 0.53
  • EV/Revenue 1.91

Profitability

  • Revenue Growth 12.0%
  • Gross Margin 44.0%
  • Operating Margin -2.3%
  • Net Margin -20.0%
  • ROE -7.0%

Financial strength

  • Cash $325.80M
  • Debt $53.97M
  • Net Cash $271.83M
  • Free Cash Flow $38.32M
  • Current Ratio 2.5

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Azenta, Inc. (AZTA).

View Methodology & FAQ →